Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study

The current role of chemotherapy in pancreatic carcinoma is limited, and progress in the treatment of this disease represents a significant challenge to medical oncology. The most promising drug under study is gemcitabine, a relatively new antimetabolite that represents an attractive candidate for c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Neri, B, Cini, G, Doni, L, Fulignati, C, Turrini, M, Pantalone, D, Mini, E, De Luca Cardillo, C, Fioretto, L M, Ribecco, A S, Moretti, R, Scatizzi, M, Zocchi, G, Quattrone, A
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2002
Teme:
Clinical
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376146/
https://ncbi.nlm.nih.gov/pubmed/12189543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600482
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki